Publikationen
| 1. | Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB
Toxins (Basel). 2010 Oct;2(10):2428-66.
|
| 2. | Targeting Sp1 transcription factors in prostate cancer therapy. Sankpal UT, Goodison S, Abdelrahim M, Basha R
Med Chem. 2011 Sep;7(5):518-25.
|
| 3. | Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M
Clin Pharmacokinet. 2011 Jun;50(6):349-69.
|
| 4. | Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Clark CE, Arnold E, Lasserson TJ, Wu T
Prim Care Respir J. 2010 Dec;19(4):307-14.
|
| 5. | Traditional herbal remedies that influence cell adhesion molecule activity. Spelman K, Aldag R, Hamman A, Kwasnik EM, Mahendra MA, Obasi TM, Morse J, Williams EJ
Phytother Res. 2011 Apr;25(4):473-83.
|
| 6. | A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. Rahimi R, Shams-Ardekani MR, Abdollahi M
World J Gastroenterol. 2010 Sep;16(36):4504-14.
|
| 7. | Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Ammon HP
Phytomedicine. 2010 Sep;17(11):862-7.
|
| 8. | Complementary therapies, herbs, and other OTC agents: Boswellia (Boswellia serrata). Cassileth B
Oncology (Williston Park). 2009 Nov;23(12):1108.
|
| 9. | Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. Moussaieff A, Mechoulam R
J Pharm Pharmacol. 2009 Oct;61(10):1281-93.
|
| 10. | Recent developments in anti-inflammatory natural products. Gautam R, Jachak SM
Med Res Rev. 2009 Sep;29(5):767-820.
|
| 11. | Boswellic acids: a group of medicinally important compounds. Shah BA, Qazi GN, Taneja SC
Nat Prod Rep. 2009 Jan;26(1):72-89.
|
| 12. | In vitro screening for the tumoricidal properties of international medicinal herbs. Mazzio EA, Soliman KF
Phytother Res. 2009 Mar;23(3):385-98.
|
| 13. | Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Chande N, MacDonald JK, McDonald JW
Am J Gastroenterol. 2009 Jan;104(1):235-41; quiz 234, 242.
|
| 14. | Frankincense: systematic review. Ernst E
BMJ. 2008;337(0):a2813.
|
| 15. | [Gold, frankincense and myrrh]. Mayer JG
Dtsch Med Wochenschr. 2008 Dec;133(51-52):2665-8.
|
| 16. | Boswellia serrata. Monograph.
Altern Med Rev. 2008 Jun;13(2):165-7.
|
| 17. | Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in chinese traditional medicine. Shen T, Lou HX
Chem Biodivers. 2008 Apr;5(4):540-53.
|
| 18. | Interventions for treating collagenous colitis. Chande N, McDonald JW, Macdonald JK
Cochrane Database Syst Rev. 2008;0(2):CD003575.
|
| 19. | A database on endemic plants at Tirumala hills in India. Latheef SA, Prasad B, Bavaji M, Subramanyam G
Bioinformation. 2008;2(6):260-2.
|
| 20. | A review of complementary and alternative approaches to immunomodulation. Clarke JO, Mullin GE
Nutr Clin Pract. 2008 Feb;23(1):49-62.
|
| 21. | Nutraceuticals in the management of osteoarthritis. Clayton JJ
Orthopedics. 2007 Aug;30(8):624-9; quiz 630-1.
|
| 22. | Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Chrubasik JE, Roufogalis BD, Chrubasik S
Phytother Res. 2007 Jul;21(7):675-83.
|
| 23. | CEC and EKC of natural compounds. Scherz H, Huck CW, Bonn GK
Electrophoresis. 2007 Jun;28(11):1645-57.
|
| 24. | Boswellic acids: biological actions and molecular targets. Poeckel D, Werz O
Curr Med Chem. 2006;13(28):3359-69.
|
| 25. | Conservation biology: unkind cuts for incense. Moore PD
Nature. 2006 Dec;444(7121):829.
|
| 26. | Interventions for treating collagenous colitis. Chande N, McDonald JW, MacDonald JK
Cochrane Database Syst Rev. 2006;0(4):CD003575.
|
| 27. | Boswellic acids in chronic inflammatory diseases. Ammon HP
Planta Med. 2006 Oct;72(12):1100-16.
|
| 28. | Systematic review: microscopic colitis. Nyhlin N, Bohr J, Eriksson S, Tysk C
Aliment Pharmacol Ther. 2006 Jun;23(11):1525-34.
|
| 29. | Natural products and anti-inflammatory activity. Yuan G, Wahlqvist ML, He G, Yang M, Li D
Asia Pac J Clin Nutr. 2006;15(2):143-52.
|
| 30. | Review article: complementary and alternative therapies for inflammatory bowel disease. Langmead L, Rampton DS
Aliment Pharmacol Ther. 2006 Feb;23(3):341-9.
|
| 31. | Interventions for treating collagenous colitis. Chande N, McDonald JW, Macdonald JK
Cochrane Database Syst Rev. 2005;0(4):CD003575.
|
| 32. | Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration. Basch E, Boon H, Davies-Heerema T, Foppo I, Hashmi S, Hasskarl J, Sollars D, Ulbricht C
J Herb Pharmacother. 2004;4(3):63-83.
|
| 33. | Patented antiinflammatory plant drug development from traditional medicine. Darshan S, Doreswamy R
Phytother Res. 2004 May;18(5):343-57.
|
| 34. | Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy. Wallace JM
Integr Cancer Ther. 2002 Mar;1(1):7-37; discussion 37.
|
| 35. | [Boswellic acids (the active agent in incense) for the treatment of chronic inflammatory diseases]. Ammon HP
Med Monatsschr Pharm. 2003 Sep;26(9):309-15.
|
| 36. | Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Badria FA, Mikhaeil BR, Maatooq GT, Amer MM
Z Naturforsch C. 2003 Jul-Aug;58(7-8):505-16.
|
| 37. | [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]. Ammon HP
Wien Med Wochenschr. 2002;152(15-16):373-8.
|
| 38. | The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Miller AL
Altern Med Rev. 2001 Feb;6(1):20-47.
|
| 39. | Boswellia serrata.
Altern Med Rev. 1998 Aug;3(4):306-7.
|
| 40. | Salai Guggal - Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis. Ammon HP
Eur J Med Res. 1996 May;1(8):369-70.
|
| 41. | Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China. Han R
Chin Med Sci J. 1994 Mar;9(1):61-9.
|


